ArticlePlant cell reports2026
ELF18-INDUCED LONG NONCODING RNA 19 attenuates PAMP-induced callose deposition by modulating UDP-glycosyltransferase 71B6-associated ABA levels.
Article in Plant cell reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
key messageCis-natural antisense transcript ELENA19 attenuates PAMP-triggered immunity by modulating ABA- and PAMP-inducible UGT71B6 expression, resulting in increased ABA levels and reduced ET-dependent flg22-induced callose deposition in Arabidopsis. Long noncoding RNAs (lncRNAs) have emerged as crucial regulators of various biological processes. However, the roles of lncRNAs in pathogen-associated molecular pattern (PAMP)-triggered immunity (PTI) remain largely unexplored in plants. Based on our previous custom lncRNA array analysis of Arabidopsis seedlings treated with PAMPs (elf18 and flg22), we identified a novel ELF18-INDUCED LONG NONCODING RNA, ELENA19. In this study, we characterized the function of ELENA19 as a natural antisense transcript of UDP-glycosyltransferase 71B6 (UGT71B6), which is responsible for the glycosylation of abscisic acid (ABA). ELENA19 expression was rapidly upregulated upon treatment with ABA or PAMPs (flg22 and elf18). Among the genes neighboring ELENA19, only UGT71B6 was responsive to both ABA and PAMP treatments. UGT71B6 expression was significantly attenuated in ELENA19-overexpressing (OX) plants compared to wild-type (WT) plants after PAMP or ABA treatment. ELENA19 OX plants were hypersensitive to ABA during germination and had higher endogenous ABA levels than WT plants, suggesting that ELENA19 down-regulates UGT71B6 expression and enhances endogenous ABA levels. Flg22-triggered callose deposition was reduced, and the expression of ethylene (ET)-dependent Flg22-induced genes was significantly down-regulated in ELENA19 OX plants compared to WT plants, confirming the antagonistic interaction between ABA and ET signaling in the flg22-mediated immune response. These results demonstrate that ELENA19 attenuates PAMP-triggered immunity by modulating UGT71B6 expression.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.